SEP 4, 2026 · PHASE 2 TRIAL
Phase 2 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
ClinicalTrials.gov
Phase 2 trial with planned enrollment of 120 participants and surrogate endpoint (percent change in body weight); results are not yet reported in this registry record.
Reported
Sample size120
PhasePhase 2
Primary endpointPercentage Change from Baseline in Body Wei…